And as a rule, they spend under a third what the bigs do, quarter to quarter. But these smaller ones don't ratchet back spending as much as some -- during a presidential election quarter, as my graphic shows at right. Here's what Abbott bent ears on, with Baxter's disclosures due up this afternoon, if I get a free five minutes:
. . .S. 2477/H.R. 1770 Equitable Community Access to Pharmacist Services Act; H.R. 2369 Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2023; Proposals related to sterilization of medical devices; Proposals related to the President's Emergency Plan for AIDS Relief (PEPFAR); Proposals related to PT/INR (Prothrombin Time/International Normalized Ratio) testing; Proposals related to heart failure technology. . . .
S. 1000/H.R. 1835 Saving Access to Laboratory Services Act; H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act of 2023; Proposals regarding PAMA regulations and changes to modernize and update the Clinical Laboratory Fee Schedule; Proposals related to Medicare coverage of continuous glucose monitors; Proposals to ensure Medicare coverage for emerging medical device technology; Proposals related to medical device reimbursement and coverage. . . .
Proposals related to U.S. global health programs and pandemic preparedness; Proposals to advance global virus surveillance; Proposals related to preserving critical medical supply chains. . . .
Proposals related to access to infant formula; Proposals related to third party litigation reform; Public Law 115-97 The Tax Cuts and Jobs Act. . . .
Public Law 117-169 Inflation Reduction Act of 2022; Proposals to reform domestic and international tax structures. . . .
Now you know. . . onward, smiling -- on a sunny Monday.
नमस्ते
No comments:
Post a Comment